Nasdaq

2024 - 12 - 19

Altimmune Added to Nasdaq Biotechnology Index (GlobeNewswire)

GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it...

MindMed to Be Added to the Nasdaq Biotechnology Index (Canada.com)

NEW YORK — Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product ...

Post cover
Image courtesy of "Business Wire"

Castle Biosciences Reports Inducement Grants Under Nasdaq ... (Business Wire)

Castle's Compensation Committee of its Board of Directors granted restricted stock units (RSUs) as inducement material to new employees.

Post cover
Image courtesy of "Business Wire"

MindMed to Be Added to the Nasdaq Biotechnology Index (Business Wire)

(Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, ...

Post cover
Image courtesy of "AccessWire"

Favo Capital Files Its Initial Application With The NASDAQ Stock ... (AccessWire)

LAUDERHILL, FL / ACCESSWIRE / December 19, 2024 / FAVO Capital, Inc. (OTC PINK:FAVO), a leading provider of alternative financing solutions in the Private ...

Post cover
Image courtesy of "Business Wire"

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635 ... (Business Wire)

Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purc.

Post cover
Image courtesy of "GlobeNewswire"

Aptose Announces Positive Decision by Nasdaq Hearings Panel (GlobeNewswire)

SAN DIEGO and TORONTO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage ...

Post cover
Image courtesy of "Business Wire"

Arrowhead Pharmaceuticals Reports Inducement Grants under ... (Business Wire)

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on December 13, 202.

Post cover
Image courtesy of "Smarter Analyst"

Aptose Biosciences Granted Nasdaq Compliance Extension (Smarter Analyst)

An update from Aptose Biosciences ( ($TSE:APS) ) is now available. Aptose Biosciences announced that the Nasdaq Hearings Panel has granted an extension for ...

Molecular Templates Announces Notice of Delisting and Failure to ... (GlobeNewswire)

AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a...

89bio Announces Inducement Grants Under Nasdaq Listing Rule ... (GlobeNewswire)

SAN FRANCISCO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company...

Explore the last week